Result
This study was conducted from January 2019 to September 2019. It consisted of 25 children with pneumonia and asthma (group I), 25 children with pneumonia (group II), and 25 healthy children (group III) with 2 to 6 years of age.
Table 1 presents the children’s anthropometric variables.
Results showed a significant reduction in TAC in groups I and II (0.997±0.22 and 1.23±0.21mmol/l, respectively) compared with group III (1.46±0.19 mmol/l), which was higher in group I than in group II. Also, a major increase was observed in MDA and TNF-α in groups I (2.57±0.40µmol/l, 6.94±1.61mmol/l, respectively) and II (2.11±0.26 µmol/l, 5.54±1.84mmol/l, respectively) compared with group III (1.89±0.27
µmol/l, 3.42±1.32mmol/l, respectively), which was significantly higher in group I than in group II (Table2).  VCAM-1 and PAI- 1 as ED biomarkers increased significantly in group I (1.5.±0.62 mmol/l and 10.52±3.2 AU/ml, respectively) compared with groups II (1.06±0.53 mmol/l and 8.23±3.4 AU/ml, respectively) and III (0.6± 0.35 mmol/l and 2.39±0.83 AU/ml, respectively). VCAM-1 and PAI- 1 increased significantly in group II compared with groups III (Table2).